Studies conflict on aggressive diabetes treatment

02/13/2008 | Reuters

Intensive treatment does not increase the risk of death in Type 2 diabetes patients, according to early results from a large study. The findings contradict the results of a recent U.S. trial that found a slight mortality increase in patients whose blood sugar had been reduced to near-normal ranges. Researchers say the new findings were based on more than twice as much data as the previous study.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN